In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with ...

As viral vaccines are increasingly used to meet global health needs, the pharmaceutical industry is manufacturing larger ...

Entos Pharmaceuticals has announced an investment of C$62m ($43.05m) from the governments of Canada and Alberta for an R&D facility.

US official says Trump confident China will not invade Taiwan during his term The isothermal nucleic acid amplification technology market has evolved significantly due to the growing need for ...

In the pursuit of understanding the pathogenic expression mechanisms of bacteria and the advancements in biofoundry ...

Purdue University-connected startup Molecular Intelligence supports research scientists in bioengineering, medical science ...

Quantum-Si's next-gen protein sequencing tech and growth partnerships show promise, but high costs, financial risks, and ...

Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic diseases marked by too low levels of specific cellular proteins.

Lallemand Health Solutions is proud to announce the latest findings from a comprehensive study on Cerebiome, a pioneering ...

Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable ...

With grant funding from governments at multiple levels in Canada, Entos Pharmaceuticals is looking to plant roots at a CAD $198.5 million ($137.2 million) R&D and manufacturing hub in Edmonton. | The ...